Simply put it this way:
".... in respect of preparation and finalising the release of the European Medicines Agency Paediatric Committee Opinion adoption of the Paediatric Investigation Plan for ATL1102 for the treatment of Duchenne muscular dystrophy;
Go back to the announcement dated 30th September 2021:
“With the final opinion due in the coming weeks, we are finalising the site evaluations and selections for the conduct of the trial and progressing preparations of the clinical trial applications for submission to the national competent authorities,” Ms Desem said.
Can't be any negative feedback at this stage in my own opinion.......Other than that... BONUS!!
Simply put it this way:".... in respect of preparation and...
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.9¢ |
Change
-0.001(1.25%) |
Mkt cap ! $83.73M | |||
| Open | High | Low | Value | Volume |
| 8.1¢ | 8.2¢ | 7.9¢ | $153.8K | 1.914M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 927041 | 7.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.1¢ | 218878 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| PER (ASX) Chart |